Treos Bio, Inc.

11 articles about Treos Bio, Inc.

• 

  Global Roundup: Celltrion Prepares to Trap COVID-19 in Phase III

  2/10/2022

  Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

• Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine

  6/15/2020

  Treos Bio Limited, a clinical stage biopharma company developing targeted peptide cancer immunotherapies, said that it has developed and successfully tested in silico a preventive COVID-19 peptide vaccine and has transferred all rights, including pending patent applications, to a newly formed subsidiary, PepTC Vaccines Limited.

• Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation

  5/29/2020

  Treos Bio Limited, a clinical stage biopharma company developing precision peptide cancer immunotherapies, today presented positive final data from a Phase I/II study of PolyPEPI1018, its off-the-shelf multi-peptide treatment, in microsatellite stable metastatic colorectal cancer (MSS mCRC) patients during an online poster presentation released today at the 2020 ASCO Annual Meeting.

• Treos Bio Announces FDA Approval of IND of Its First PolyPEPI Precision Cancer Vaccine for Metastatic Colorectal Cancer

  1/24/2018

  The presentation at the EBMT Conference will entail detailed correlative analyses between clinical benefit

• Treos Bio Enters Into Agreement With PPD To Manage First-In-Man Trial Of Its Lead Therapeutic Cancer Vaccine Program

  9/21/2017

• Treos Bio Names Group Of Leading Clinical And Regulatory Experts To Clinical Advisory Board

  4/27/2017

• Treos Bio Announces Filing Of Key Patent Applications On Its Precision Therapeutic Cancer Vaccine Development Platform And Its Compositions For Colorectal And Breast Cancers

  4/3/2017

• Treos Bio Announces Filing Of Key Patent Applications On Its Precision Therapeutic Cancer Vaccine Development Platform And Its Compositions For Colorectal And Breast Cancers

  4/3/2017

• Precision Therapeutics, Inc. Cancer Vaccine Developer Treos Bio Opens U.S. Headquarters In San Francisco

  3/21/2017

• Treos Bio Raises $8 Million In Private Investment Round

  2/14/2017

• Treos Bio, Developer Of Precision Cancer Vaccines, Emerges From Stealth

  6/3/2016